Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia and Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04606433
What this trial is testing

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 47
Very early researchLooking for participantsNCT06696833
What this trial is testing

Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Soochow University 18
Not applicableStudy completedNCT03255668
What this trial is testing

Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia

Who this might be right for
Mercaptopurine Adverse ReactionLeukemia, Lymphoblastic
Universitas Indonesia 106
Early research (Phase 1)Study completedNCT03885947
What this trial is testing

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Who this might be right for
Hematological MalignancyAcute Leukemia in RemissionAcute Lymphoblastic Leukemia in Remission+3 more
Alla Keyzner 7
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Study completedNCT01702155
What this trial is testing

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic Leukemia
Delta-Fly Pharma, Inc. 69
Early research (Phase 1)Study completedNCT03181126
What this trial is testing

Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Lymphoblastic Lymphoma
AbbVie 69
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Large-scale testing (Phase 3)UnknownNCT00003815
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Scotland and Newcastle Lymphoma Group
Not applicableStudy completedNCT03627208
What this trial is testing

Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch

Who this might be right for
Leukemia, Lymphoblastic, AcuteALL, Childhood
National Cancer Institute (NCI) 150
Testing effectiveness (Phase 2)Study completedNCT00005985
What this trial is testing

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota 213
Not applicableStudy completedNCT04843150
What this trial is testing

Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study

Who this might be right for
Acute Lymphoblastic Leukemia
Aarhus University Hospital 320
Not applicableStudy completedNCT01295476
What this trial is testing

Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 135
Not applicableNot Yet RecruitingNCT06050850
What this trial is testing

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

Who this might be right for
ALL, ChildhoodBehavior, Health
University of Kansas Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00025545
What this trial is testing

Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT05544019
What this trial is testing

Study of SGR-1505 in Mature B-Cell Neoplasms

Who this might be right for
Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more
Schrödinger, Inc. 98
Testing effectiveness (Phase 2)Study completedNCT00133367
What this trial is testing

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

Who this might be right for
Multiple MyelomaNon-Hodgkin's LymphomaHodgkin's Disease+2 more
Massachusetts General Hospital 32
Testing effectiveness (Phase 2)Study completedNCT00290992
What this trial is testing

Rasburicase for Hyperuricemia

Who this might be right for
Nutritional and Metabolic Diseases
Sanofi 30
Very early researchWithdrawnNCT07196111
What this trial is testing

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Who this might be right for
B Acute Lymphoblastic Leukemia/Lymphoma
Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)Active Not RecruitingNCT03162536
What this trial is testing

Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Who this might be right for
Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 190
Next Page